|
| 上皮性卵巢癌复发风险评估方法学中国专家共识（2025年版） |
| Chinese expert consensus on risk assessment methodology for epithelial ovarian cancer |
| 投稿时间：2025-06-03 修订日期：2025-09-30 |
| DOI： |
|
 |
| 中文关键词: 卵巢癌 复发 风险评估 专家共识 |
| 英文关键词:Ovarian cancer Recurrence Risk assessment Expert consensus |
| 基金项目:辽宁省重点研发项目（2024JH2/102500019）；辽宁省“兴辽英才计划”项目（XLYC2412037）；2022年沈阳市科技计划（22-321-33-08）；沈阳市科技局2023年助力中国医科大学高质量发展专项（23-506-3-01-10） |
|
| 摘要点击次数: 111 |
| 全文下载次数: 1 |
| 中文摘要: |
| 卵巢癌是女性生殖系统常见的恶性肿瘤之一，大多数上皮性卵巢癌对化疗敏感，经标准一线方案治疗后可达到完全或部分缓解，但即使联合手术、化疗及基于生物标志物的维持治疗，绝大多数上皮性卵巢癌都会复发。复发性卵巢癌即使接受进一步的规范化治疗，对后线治疗的耐药率逐渐增高，导致治疗棘手。因此，准确识别和预判高复发风险人群，对改善卵巢癌患者预后具有重要意义。本共识基于文献证据，制定卵巢癌复发风险评估的方法学依据，供借鉴参考。 |
| 英文摘要: |
| Ovarian cancer is one of the most common malignancies of the female reproductive system, and most epithelial ovarian cancers are sensitive to chemotherapy and can achieve complete or partial remission after standard first-line treatment, and the vast majority of epithelial ovarian cancers will recur even in combination with biomarker-based maintenance therapy. Even if recurrent ovarian cancer is treated with further standardized treatment, the resistance rate to later chemotherapy gradually increases, which makes the treatment difficult. Therefore, it is of great significance to accurately identify and predict groups with high risk of recurrence to improve the prognosis of ovarian cancer patients. Based on the literature evidence, this consensus formulates a methodological basis for the risk assessment of ovarian cancer recurrence for reference. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |